Nutrien Ltd. ( NTR Quick Quote NTR - Free Report) is set to release third-quarter 2020 results on Nov 2, after the closing bell.
Nutrien’s third-quarter results are likely to reflect the benefits of strong demand for phosphate and potash. The company has a trailing four-quarter negative earnings surprise of 76.9%, on average.
The company’s shares have lost 18.9% in the past year compared with the
industry’s 9% decline.
Let’s see how things are shaping up for this announcement.
What to Expect in Q3
In second-quarter 2020 earnings call, the company stated that global urea demand is supported by strong consumption in many key regions, particularly in India. It expects the pace of Chinese urea exports to rise in the second half of 2020. Also, global potash buying is expected to remain strong on the back of signing of the China and India potash contracts.
Further, global phosphate prices are likely to be supported by an expected strength in second-half demand in India and Brazil. Also, improved industrial utilization for ammonia in Asian markets is supporting both demand and prices in the region.
What do the Estimates Indicate?
The Zacks Consensus Estimate for Nutrien’s third-quarter consolidated sales is currently pegged at $3,931 million, which calls for a decline of 4.9% from the year-ago quarter’s tally.
The Zacks Consensus Estimate for net sales in the Phosphates segment is currently pegged at $281 million, which calls for a rise of 12.4% sequentially.
Moreover, the consensus mark for net sales in the Potash segment is currently pegged at $566 million, which calls for a fall of 3.7% sequentially.
The consensus mark for net sales in the Nitrogen segment is currently pegged at $598 million, which suggests a fall of 14.1% sequentially.
Our proven model does not predict an earnings beat for Nutrien this season. The combination of a positive
Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. But that’s not the case here. Earnings ESP: Earnings ESP for Nutrien is 0.00%. The Most Accurate Estimate and the Zacks Consensus Estimate both are currently pegged at 7 cents. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter. Zacks Rank: Nutrien carries a Zacks Rank #3. You can see . the complete list of today’s Zacks #1 Rank stocks here Stocks Likely to Beat Estimates
Here are some companies that you may want to consider as our model shows that they have the right combination of elements to post an earnings beat this quarter:
Olin Corporation ( OLN Quick Quote OLN - Free Report) , scheduled to release third-quarter 2020 earnings on Nov 4, has an Earnings ESP of +6.25% and carries a Zacks Rank #3. Albemarle Corporation ( ALB Quick Quote ALB - Free Report) , scheduled to release third-quarter 2020 earnings on Nov 4, has an Earnings ESP of +5.73% and carries a Zacks Rank #3. Domtar Corporation ( UFS Quick Quote UFS - Free Report) , slated to release third-quarter 2020 earnings on Nov 6, has an Earnings ESP of +57.14% and carries a Zacks Rank #3. Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by referendums and legislation, this industry is expected to blast from an already robust $17.7 billion in 2019 to a staggering $73.6 billion by 2027. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot stocks we're targeting >>